Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
13.58
+0.38 (2.92%)
Jun 29, 2026, 3:11 PM EDT - Market open
Mesoblast Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Mesoblast stock have an average target of 35, which predicts an increase of 157.83% from the current stock price of 13.58.
Analyst Consensus: Buy
* Price targets were last updated on Apr 15, 2026.
Analyst Ratings
The average analyst rating for Mesoblast stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +157.83% | Apr 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $35 | Buy | Reiterates | $35 | +157.83% | Apr 10, 2026 |
Financial Forecast
Revenue This Year
115.58M
from 17.20M
Increased by 572.07%
Revenue Next Year
200.27M
from 115.58M
Increased by 73.27%
EPS This Year
-0.04
from -0.07
EPS Next Year
0.03
from -0.04
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 134.2M | 298.3M | |
| Avg | 115.6M | 200.3M | |
| Low | 107.3M | 133.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 680.0% | 158.1% | |
| Avg | 572.1% | 73.3% | |
| Low | 524.0% | 15.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.04 | 0.03 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.